99 related articles for article (PubMed ID: 33152105)
1. Peritoneal HPV-DNA test in cervical cancer (PIONEER study): A proof of concept.
Bizzarri N; Pedone Anchora L; Cattani P; De Vincenzo R; Marchetti S; Conte C; Chiantera V; Gallotta V; Gueli Alletti S; Vizzielli G; Costantini B; Fagotti A; Fanfani F; Scambia G; Ferrandina G
Int J Cancer; 2021 Mar; 148(5):1197-1207. PubMed ID: 33152105
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
Chong GO; Lee YH; Han HS; Lee HJ; Park JY; Hong DG; Lee YS; Cho YL
Gynecol Oncol; 2018 Jan; 148(1):97-102. PubMed ID: 29153540
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of human papillomavirus genotype in cervical adeno-adenosquamous carcinoma.
Lai CH; Chou HH; Chang CJ; Wang CC; Hsueh S; Huang YT; Chen YR; Chang HP; Chang SC; Lin CT; Chao A; Qiu JT; Huang KG; Chen TC; Jao MS; Chen MY; Liou JD; Huang CC; Chang TC; Patsner B
Eur J Cancer; 2013 Feb; 49(3):633-41. PubMed ID: 23031554
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
[TBL] [Abstract][Full Text] [Related]
5. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
[TBL] [Abstract][Full Text] [Related]
6. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.
Lai CH; Chang CJ; Huang HJ; Hsueh S; Chao A; Yang JE; Lin CT; Huang SL; Hong JH; Chou HH; Wu TI; Huang KG; Wang CC; Chang TC
J Clin Oncol; 2007 Aug; 25(24):3628-34. PubMed ID: 17704412
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
8. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia.
Ali KE; Mohammed IA; Difabachew MN; Demeke DS; Haile T; Ten Hove RJ; Kumssa TH; Woldu ZL; Haile EL; Tullu KD
BMC Cancer; 2019 Aug; 19(1):768. PubMed ID: 31382907
[TBL] [Abstract][Full Text] [Related]
9. Lymph node human papillomavirus DNA positivity in uterine cervical cancers and its relationship with prognostic factors.
Baser E; Can F; Unlukaplan M; Ayhan A
Int J Gynecol Cancer; 2011 Jan; 21(1):117-22. PubMed ID: 21330836
[TBL] [Abstract][Full Text] [Related]
10. Impact of HPV 16/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy - A prospective observational study.
Mahantshetty U; Teni T; Naga P; Hotwani C; Umesh S; Kannan S; Hande V; Pawar S; Engineer R; Chopra S; Deodhar K; Maheshwari A; Gurram L; Gupta S; Shrivastava SK
Gynecol Oncol; 2018 Feb; 148(2):299-304. PubMed ID: 29203175
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil.
Fernandes JV; Meissner Rde V; Carvalho MG; Fernandes TA; Azevedo PR; de Azevedo JW; de Araújo JM
Mol Med Rep; 2011; 4(6):1321-6. PubMed ID: 21887467
[TBL] [Abstract][Full Text] [Related]
13. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
14. P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers.
da Mata S; Ferreira J; Nicolás I; Esteves S; Esteves G; Lérias S; Silva F; Saco A; Cochicho D; Cunha M; Del Pino M; Ordi J; Félix A
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669021
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the analytical and clinical performances of Abbott RealTime High Risk HPV, Hybrid Capture 2, and DNA Chip assays in gynecology patients.
Park S; Kang Y; Kim DG; Kim EC; Park SS; Seong MW
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):432-6. PubMed ID: 23791386
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery.
Turco LC; Pedone Anchora L; Fedele C; Inzani F; Piermattei A; Martini M; Volpe M; Marchetti S; Santangelo R; Bizzarri N; Cosentino F; Vargiu V; De Ninno M; Macchia G; Valentini V; Zannoni G; Scambia G; Ferrandina G
Int J Gynecol Cancer; 2023 Apr; 33(4):489-497. PubMed ID: 36720505
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus 16-positive uterine cervical squamous cell carcinoma with coinfection with human papillomavirus 34 has a lower incidence in lymph node metastasis than that without coinfection with human papillomavirus 34.
Michimata R; Watari H; Tomaru U; Sakuragi N; Ishizu A
Pathobiology; 2013; 80(5):259-64. PubMed ID: 23689419
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Colposcopic Biopsy Results of Patients Who have Cytomorphological Normal but HPV 16-18 or Other High-Risk HPV Subtypes Positive.
Aydoğmuş H; Aydoğmuş S
Asian Pac J Cancer Prev; 2019 Feb; 20(2):417-420. PubMed ID: 30803201
[TBL] [Abstract][Full Text] [Related]
19. Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial.
Youn JW; Hur SY; Woo JW; Kim YM; Lim MC; Park SY; Seo SS; No JH; Kim BG; Lee JK; Shin SJ; Kim K; Chaney MF; Choi YJ; Suh YS; Park JS; Sung YC
Lancet Oncol; 2020 Dec; 21(12):1653-1660. PubMed ID: 33271094
[TBL] [Abstract][Full Text] [Related]
20. High-risk human papillomavirus cervical infections among healthy women in Guadeloupe.
Cordel N; Ragin C; Trival M; Tressières B; Janky E
Int J Infect Dis; 2015 Dec; 41():13-6. PubMed ID: 26597118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
